Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Imig

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Frontiers in Physiology|February 9, 2026
Editorial: New insights on vascular and metabolic diabetic complicationsHua Mao, John D Imig, Ricardo Espinosa-Tanguma
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in HypertensionJohn D Imig, Margaret A Carpenter, Sean Shaw
Frontiers in Pharmacology|March 29, 2021
Multi-Target Approaches in Metabolic SyndromeFelix F Lillich, John D Imig, Ewgenij Proschak
PPAR Research|July 9, 2010
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated ReceptorsTengis S Pavlov, John D Imig, Alexander Staruschenko
Clinical and Experimental Pharmacology & Physiology|March 27, 2012
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenibTasuku Nagasawa, Md Abdul Hye Khan, John D Imig
American Journal of Physiology. Renal Physiology|August 9, 2002
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in miceJohn D Imig, Matthew D Breyer, Richard M Breyer
Hypertension (Dallas, Tex. : 1979)|June 2, 2020
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial LectureJohn D Imig, Wojciech K Jankiewicz, Abdul H Khan
Frontiers in Physiology|December 21, 2020
Editorial: Renal Function in Acute and Chronic Kidney DiseasesJohn D Imig, Md Abdul Hye Khan, Xueying Zhao
Biochemical Pharmacology|February 1, 2026
Renoprotective approaches against anthracycline nephrotoxicityTsigereda Weldemichael, Md Abdul Hye Khan, John D Imig
Toxicology Mechanisms and Methods|December 22, 2009
CYP450, COX-2 and Obesity Related Renal DamageJohn D Imig, Xueying Zhao, Aparajita Dey, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Frontiers in Physiology|February 9, 2026
Editorial: New insights on vascular and metabolic diabetic complicationsHua Mao, John D Imig, Ricardo Espinosa-Tanguma
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in HypertensionJohn D Imig, Margaret A Carpenter, Sean Shaw
Frontiers in Pharmacology|March 29, 2021
Multi-Target Approaches in Metabolic SyndromeFelix F Lillich, John D Imig, Ewgenij Proschak
PPAR Research|July 9, 2010
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated ReceptorsTengis S Pavlov, John D Imig, Alexander Staruschenko
Clinical and Experimental Pharmacology & Physiology|March 27, 2012
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenibTasuku Nagasawa, Md Abdul Hye Khan, John D Imig
American Journal of Physiology. Renal Physiology|August 9, 2002
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in miceJohn D Imig, Matthew D Breyer, Richard M Breyer
Hypertension (Dallas, Tex. : 1979)|June 2, 2020
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial LectureJohn D Imig, Wojciech K Jankiewicz, Abdul H Khan
Frontiers in Physiology|December 21, 2020
Editorial: Renal Function in Acute and Chronic Kidney DiseasesJohn D Imig, Md Abdul Hye Khan, Xueying Zhao
Biochemical Pharmacology|February 1, 2026
Renoprotective approaches against anthracycline nephrotoxicityTsigereda Weldemichael, Md Abdul Hye Khan, John D Imig
Toxicology Mechanisms and Methods|December 22, 2009
CYP450, COX-2 and Obesity Related Renal DamageJohn D Imig, Xueying Zhao, Aparajita Dey, et al.
Pageof 20